This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Universal Health Services (UHS) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Universal Health Services (UHS) delivered earnings and revenue surprises of 13.49% and 2.75%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for Universal Health's (UHS) Q1 Earnings?
by Zacks Equity Research
Universal Health's (UHS) first-quarter earnings are expected to have gained from better revenues and performances by its Acute Care and Behavioral Health segments.
Universal Health Services (UHS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Universal Health Services (UHS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Universal Health (UHS) Ties Up for New Psychiatric Hospital
by Zacks Equity Research
Universal Health's (UHS) affiliate Havenwyck Hospital forms a joint venture with Mercy Heath to construct a new inpatient behavioral health hospital.
Universal Health Services (UHS) Up 0.2% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Universal Health Services (UHS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Tenet Healthcare (THC) Hits 52 Week High: Will the Rally Stay?
by Zacks Equity Research
Tenet Healthcare's (THC) shares display an upsurge as investors get optimistic about its latest strategic initiatives and cost-curbing measures.
Here's Why You Should Hold on to Universal Health (UHS) Now
by Zacks Equity Research
Riding high on its solid segments and an impressive top line, Universal Health (UHS) holds enough potential to reap benefits for investors.
Universal Health (UHS) Q4 Earnings Beat, Revenues Up Y/Y
by Zacks Equity Research
Universal Health's (UHS) fourth-quarter results reflect improved revenues across the company's segments, partly offset by elevated costs.
Select Medical (SEM) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Select Medical's (SEM) Q4 results reflect solid performances by its Critical Illness Recovery and Rehabilitation Hospital segments.
Acadia Healthcare (ACHC) Q4 Earnings Top Estimates, Rise Y/Y
by Zacks Equity Research
Acadia Healthcare's (ACHC) Q4 results reflect progress in its U.S business, which gained from solid volumes, and its solid cost-management policy.
Universal Health (UHS) to Report Q4 Results: What to Expect?
by Zacks Equity Research
Universal Health's (UHS) fourth-quarter results are likely to reflect gain from better revenues.
4 Hospital Stocks to Gain From Growth in Patient Admissions
by Sapna Bagaria
Players in the hospital industry are likely to gain from increasing patient admissions, government grants and cost-control measures.
Here's Why You Should Hold MEDNAX (MD) in Your Portfolio Now
by Zacks Equity Research
Riding high on its strategic efforts and cost-cutting measures, MEDNAX (MD) holds enough potential to reap benefits for investors.
Here's Why You Should Bet on Acadia Healthcare (ACHC) Stock
by Zacks Equity Research
Acadia Healthcare (ACHC) has been benefiting from growing demand for behavioral health services, high revenues and solid cash flows.
Here's Why You Should Hold on to Universal Health (UHS) Now
by Zacks Equity Research
Rising high on solid segments and solvency levels, Universal Health (UHS) holds potential to reap benefits for investors.
Enforcement of Price Transparency Rules Puts Hospitals in a Fix
by Zacks Equity Research
Hospital companies might feel the heat from price transparency rules, effective Jan 1, 2021.
Tenet Healthcare (THC) to Rejig Business by Selling Urgent Care
by Zacks Equity Research
Tenet Healthcare (THC) to restructure its ambulatory care business by axing the urgent care business and focusing on growing the ambulatory surgery business.
Is Universal Health (UHS) a Good Value Investor Stock Now?
by Zacks Equity Research
Let's see if Universal Health (UHS) stock is a good choice for value-oriented investors right now from multiple angles.
MEDNAX's (MD) Q3 Earnings Meet Estimates, Revenues Miss
by Zacks Equity Research
MEDNAX's (MD) third-quarter results reflect muted revenues and high costs, partly offset by lower interest expense.
Humana's (HUM) Q3 Earnings Surpass Estimates, Decline Y/Y
by Zacks Equity Research
Humana's (HUM) third-quarter earnings reflect improved revenues, partly offset by expenses.
Select Medical's (SEM) Q3 Earnings Beat Mark, Improve Y/Y
by Zacks Equity Research
Select Medical's (SEM) third-quarter 2020 earnings gain traction from better revenues at its Critical Illness Recovery and Rehabilitation Hospital segments.
Teladoc (TDOC) Q3 Earnings Beat Estimates, Hikes '20 Guidance
by Zacks Equity Research
Teladoc's (TDOC) third-quarter results reflect robust revenues and solid uptick in patient visits, partially offset by elevated costs.
Acadia Healthcare's (ACHC) Shares Up on Q3 Earnings Beat
by Zacks Equity Research
Acadia Healthcare's (ACHC) shares gain on third-quarter earnings beat, which has been driven by higher revenues. However, elevated costs have partially offset the results.
Universal Health's (UHS) Q3 Earnings Surpass, Improve Y/Y
by Zacks Equity Research
Universal Health's (UHS) third-quarter results reflect higher revenues and lower expenses.
Universal Health Services (UHS) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Universal Health Services (UHS) delivered earnings and revenue surprises of 41.18% and 6.05%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?